The global beta-glucan market is projected to grow at a CAGR of approximately 7.3% within the forecast period to reach USD 525.5 Million by 2023. The market has diversified in recent time. The demand    of beta glucan sources such as yeast and fungi in fermentation process in food & beverages industry and beta glucan is used to modulate immune cells has application in  pharmaceuticals industry is increasing, which is driving the demand for global beta-glucan market. With the increasing concern about health & wellness, the demand for multifunctional beta-glucan is expected to surge in the coming years. Beta glucans are polysaccharides that are extracted from different sources such as in the cell walls of bacteria, fungi, yeasts, cereals, lichens, algae and plants, such as oats and barley. Beta-Glucans comprises group of polysaccharides that mainly occurred in cell walls having different chemical and physical properties that are dependent on the source of origin of beta gulcan. Increase in application of beta-glucan in different industries such as in pharmaceutical industry. When it comes to naturally boosting the immune system beta glucan are important weapons to fight against infections. In present times health considerations are top of mind for many consumers.

 

The body doesn’t contain or produce beta glucan naturally, the only way to intake the compound is through outside sources through yeast, mushrooms, algae and cereal, like barley, oats, and wheat. Studies have shown that beta glucan act as modulator agents that help to regulate the immune system, making it more efficient. Specifically, beta glucan stimulate the activity of macrophages, which are versatile immune cells that demolish pathogens and stimulate other immune cells to attack. Growth in the consumption of food & beverages are also driving the growth of global beta glucan market due to increase in the demand   of sources of beta glucan such as yeast, bacteria and fungi in fermentation process.

 

Food retailer Sales in USA has reached $1.57 billion in 2015, a 12 percent increased as compared to 2014 i.e. 1.40 billion. In year 2015, The Kroger Company generated sales of approximately 102.9 billion U.S. dollars.  Decrease in prices and easy availability of major raw material sources also boosting the growth of global beta glucan market. However global beta glucan market growth is hindered due to lack of availability of raw material such as molasses due to its various uses in sugar and alcohol industry.

 

On the basis of market segmentation global Beta glucans market is categorized by source, application, and category. Source is further subdivided in bacteria, fungus, yeast, Cereal, algae. On the basis of category it is subdivided in soluble and insoluble nature Beta glucan. On the basis of application it is categorized in Food & Beverages, Personal Care, Pharmaceuticals, and Animal Feed.

 

  On the basis of geographical segmentation it can be divided in four major regions North America, Europe, and Asia–Pacific, rest of the world. Europe region are the major contributor in beta glucan market with immense potential and with expanding food and beverage industry and growing applications of the sources of beta glucan in fermentation process and cereals that has fiber content is also the source of beta glucan and in production of alcoholic products industry. With the increasing consumer awareness, health concern and increase in number of heart patients, diabetes, obesity and cancer patients in Asia Pacific region is boosting the growth of global beta glucan market. However price instability of beta glucan is one of the restraints that could hamper the beta glucan market growth in Asia Pacific region.

 

Some of the key players of the global Beta glucans market are Cargill Inc, Tate & Lyle PLC, Kerry Group PLC ,Koninklijke DSM N.V., Frutarom ,Garuda International Inc. Ohly , Milliporesigma , Super Beta Glucan, Lesaffre Human Care,  Specialty Biotech Co.,Ltd., Lallemand Inc., Associated British Foods, Chr. Hansen A/S, Alltech Biotechnology(USA), LuraLean and Gistex, Maxarome. Are some of the Leading companies in food and beverage industry are strategically increasing their market share in their market through initiatives such as M&A and long-term collaborations. Alltech is an American company with operations in animal feed, nutritional food and distillation process. Under the strategic initiatives, in 2016 Alltech had acquired Coppens International of Netherlands. Coppens International basically deals with aquatic feed. In 2016 Alltech had acquired a Canadian company Masterfeeds which deals with animal nutrition in combination they focus to work on farm performance.

1.       INTRODUCTION

 

1.1. EXECUTIVE SUMMARY

 

1.2. ESTIMATION METHODOLOGY

 

 

2.       MARKET OVERVIEW

 

2.1. GLOBAL BETA GULCAN  MARKET: EVOLUTION & TRANSITION

 

2.2. MARKET DEFINITION AND SCOPE

 

2.3. INDUSTRY STRUCTURE

 

2.4. REGULATORY FRAMEWORK

 

2.5. TOTAL MARKET ANALYSIS

 

2.5.1.        TOP 5 FINDINGS

 

2.5.2.        TOP 5 OPPORTUNITY MARKETS

 

2.5.3.        TOP 5 COMPANIES

 

2.5.4.        TOP 3 COMPETITIVE STRATEGIES

 

2.6. ESTIMATION ANALYSIS

 

2.7. STRATEGIC ANALYSIS

 

2.7.1.        INVESTMENT VS. ADOPTION MODEL

 

2.7.2.        360 DEGREE INDUSTRY ANALYSIS

 

2.7.3.        PORTERS 5 FORCE MODEL

 

2.7.4.        SEE-SAW ANALYSIS

 

2.7.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

 

2.8. COMPETITIVE ANALYSIS

 

2.8.1.        KEY STRATEGIES AND ANALYSIS

 

2.8.2.        MARKET SHARE

 

2.8.3.        TOP COMPANY ANALYSIS

 

2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

 

2.9.1.        INVESTMENT OPPORTUNITIES BY REGIONS

 

2.9.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

 

2.9.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

 

 

3.       MARKET DETERMINANTS

 

3.1. MARKET DRIVERS

 

3.1.1.                    GROWING HEALTH CONCERN  AMONG CONSUMERS AND INCREASING HEALTH EXPENDITURE

 

3.1.2.                     GROWING APPLICATION OF BETA-GLUCAN IN FOOD INDUSTRY

 

3.1.3.                    DECREASING PRICES OF MAJOR RAW MATERIAL SOURCES

 

3.2. MARKET RESTRAINTS

 

3.2.1.                    INCONSISTENCY IN REGULATORY NORMS

 

3.2.2.                    VARIOUS SIDE EFFECTS OF COSNUMING BETA GLUCAN

 

3.3. MARKET OPPORTUNITIES

 

3.3.1.                    UNEXPLIOTED BETA-GLUCAN APPLICATIONS IN COSMETIC  AND MEDICINE SECTOR

 

 

 

 

 

3.4. MARKET CHALLENGES

 

3.4.1.         INCREASE IN COST OF BETA-GLUCAN EXTRACTION PROCESS

 

 

4.       MARKET SEGMENTATION

 

4.1.           GLOBAL BETA GULCAN MARKET BY SOURCE

 

4.1.1.        MARKET DEFINITION AND SCOPE

 

4.1.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

 

4.1.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

 

4.1.4.         OPPORTUNITY MATRIX

 

4.1.5.         MARKET SEGMENTATION

 

4.1.5.1.                      GLOBAL BACTERIA MARKET

 

4.1.5.1.1.         APPLICATIONS

 

4.1.5.1.2.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.1.5.1.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.1.5.1.4.         TOP PLAYERS & KEY PRODUCTS

 

4.1.5.1.5.         KEY CONCLUSIONS

 

4.1.5.2.                      GLOBAL  FUNGUS MARKET

 

4.1.5.2.1.         APPLICATIONS

 

4.1.5.2.2.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.1.5.2.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.1.5.2.4.         TOP PLAYERS & KEY PRODUCTS

 

4.1.5.2.5.         KEY CONCLUSIONS

 

4.1.5.3.                      GLOBAL YEAST  MARKET

 

4.1.5.3.1.         APPLICATIONS

 

4.1.5.3.2.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.1.5.3.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.1.5.3.4.         TOP PLAYERS & KEY PRODUCTS

 

4.1.5.3.5.         KEY CONCLUSIONS

 

4.1.5.4.                      GLOBAL CEREAL  MARKET

 

4.1.5.4.1.         APPLICATIONS

 

4.1.5.4.2.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.1.5.4.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.1.5.4.4.         TOP PLAYERS & KEY PRODUCTS

 

4.1.5.4.5.         KEY CONCLUSIONS

 

4.1.5.5.                      GLOBAL ALGAE  MARKET

 

4.1.5.5.1.         APPLICATIONS

 

4.1.5.5.2.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.1.5.5.3.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.1.5.5.4.         TOP PLAYERS & KEY PRODUCTS

 

4.1.5.5.5.         KEY CONCLUSIONS

 

4.2.           GLOBAL BETA GULCAN MARKET BY END USER INDUSTRY

 

4.2.1.        MARKET DEFINITION AND SCOPE

 

4.2.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

 

4.2.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

 

4.2.4.         OPPORTUNITY MATRIX

 

4.2.5.         MARKET SEGMENTATION

 

4.2.5.1.                      GLOBAL  FOOD & BEVERAGES  MARKET

 

4.2.5.1.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.2.5.1.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.2.5.1.3.         TOP PLAYERS & KEY PRODUCTS

 

4.2.5.1.4.         KEY CONCLUSIONS

 

4.2.5.2.                      GLOBAL PERSONAL CARE  MARKET

 

4.2.5.2.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.2.5.2.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.2.5.2.3.         TOP PLAYERS & KEY PRODUCTS

 

4.2.5.2.4.         KEY CONCLUSIONS

 

4.2.5.3.                      GLOBAL PHARMACEUTICALS MARKET

 

4.2.5.3.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.2.5.3.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.2.5.3.3.         TOP PLAYERS & KEY PRODUCTS

 

4.2.5.3.4.         KEY CONCLUSIONS

 

4.2.5.4.                      GLOBAL ANIMAL FEED MARKET

 

4.2.5.4.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.2.5.4.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.2.5.4.3.         TOP PLAYERS & KEY PRODUCTS

 

4.2.5.4.4.         KEY CONCLUSIONS

 

4.3.            GLOBAL BETA GULCAN MARKET BY CATEGORY

 

4.3.1.        MARKET DEFINITION AND SCOPE

 

4.3.2.        DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

 

4.3.3.        COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

 

4.3.4.         OPPORTUNITY MATRIX

 

4.3.5.         MARKET SEGMENTATION

 

4.3.5.1.                       GLOBAL INSOLUBLE BETA GLUCAN MARKET

 

4.3.5.1.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.3.5.1.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.3.5.1.3.         TOP PLAYERS & KEY PRODUCTS

 

4.3.5.1.4.         KEY CONCLUSIONS

 

4.3.5.2.                      GLOBAL  SOLUBLE BETA GLUCAN  MARKET

 

4.3.5.2.1.         ADOPTION SCENARIO & MARKET DETERMINANTS

 

4.3.5.2.2.         MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

4.3.5.2.3.         TOP PLAYERS & KEY PRODUCTS

 

4.3.5.2.4.         KEY CONCLUSIONS

 

 

5.       COMPETITIVE LANDSCAPE

 

5.1. KEY STRATEGIES

 

5.1.1.        LIST OF MERGERS & ACQUISITION

 

5.1.2.        LIST OF JOINT VENTURES

 

5.1.3.        LIST OF PRODUCT LAUNCH

 

5.1.4.        LIST OF PARTNERSHIPS

 

5.2. TOP 10 COMPANY ANALYSIS

 

 

6.      GLOBAL BETA GULCAN MARKET BY REGION

 

6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

 

6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

 

6.3. OPPORTUNITY MATRIX

 

6.4.  GEOGRAPHIC SEGMENTATION

 

6.4.1.     NORTH AMERICA

 

6.4.1.1.  INDUSTRY APPLICATION ANALYSIS

 

6.4.1.2.  TOP COUNTRY ANALYSIS

 

6.4.1.2.1.    U.S.

 

6.4.1.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.1.2.1.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.1.2.1.3.   KEY CONCLUSIONS

 

6.4.1.2.2.    CANADA

 

6.4.1.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.1.2.2.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.1.2.2.3.   KEY CONCLUSIONS

 

6.4.2.     EUROPE

 

6.4.2.1.  INDUSTRY APPLICATION ANALYSIS

 

6.4.2.2.  TOP COUNTRY ANALYSIS

 

6.4.2.2.1.    UK

 

6.4.2.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.2.2.1.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.2.2.1.3.   KEY CONCLUSIONS

 

6.4.2.2.2.    FRANCE

 

6.4.2.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.2.2.2.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.2.2.2.3.   KEY CONCLUSIONS

 

6.4.2.2.3.    GERMANY

 

6.4.2.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.2.2.3.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.2.2.3.3.   KEY CONCLUSIONS

 

6.4.2.2.4.    SPAIN

 

6.4.2.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.2.2.4.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.2.2.4.3.   KEY CONCLUSIONS

 

6.4.2.2.5.    ITALY

 

6.4.2.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.2.2.5.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.2.2.5.3.   KEY CONCLUSIONS

 

6.4.2.2.6.    REST OF EUROPE

 

6.4.2.2.6.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.2.2.6.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.2.2.6.3.   KEY CONCLUSIONS

 

6.4.3.     ASIA PACIFIC

 

6.4.3.1.  INDUSTRY APPLICATION ANALYSIS

 

6.4.3.2.  TOP COUNTRY ANALYSIS

 

6.4.3.2.1.    CHINA

 

6.4.3.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.3.2.1.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.3.2.1.3.   KEY CONCLUSIONS

 

6.4.3.2.2.    INDIA

 

6.4.3.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.3.2.2.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.3.2.2.3.   KEY CONCLUSIONS

 

6.4.3.2.3.    JAPAN

 

6.4.3.2.3.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.3.2.3.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.3.2.3.3.   KEY CONCLUSIONS

 

6.4.3.2.4.    SOUTH KOREA

 

6.4.3.2.4.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.3.2.4.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.3.2.4.3.   KEY CONCLUSIONS

 

6.4.3.2.5.    AUSTRALIA

 

6.4.3.2.5.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.3.2.5.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.3.2.5.3.   KEY CONCLUSIONS

 

6.4.3.2.6.    REST OF ASIA PACIFIC

 

6.4.3.2.6.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.3.2.6.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.3.2.6.3.   KEY CONCLUSIONS

 

6.4.4.     ROW

 

6.4.4.1.  INDUSTRY APPLICATION ANALYSIS

 

6.4.4.2.  TOP COUNTRY ANALYSIS

 

6.4.4.2.1.    LATIN AMERICA

 

6.4.4.2.1.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.4.2.1.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.4.2.1.3.   KEY CONCLUSIONS

 

6.4.4.2.2.    MIDDLE EAST & AFRICA

 

6.4.4.2.2.1.   MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)

 

6.4.4.2.2.2.   TOP PLAYERS & KEY PRODUCTS

 

6.4.4.2.2.3.   KEY CONCLUSIONS

 

 

7.       COMPANY PROFILES

 

7.1.           ALLTECH BIOTECHNOLOGY

 

7.1.1.          OVERVIEW

 

7.1.2.        PRODUCT PORTFOLIO

 

7.1.3.        KEY INNOVATION SECTOR

 

7.1.4.        STRATEGIC INITIATIVES

 

7.1.5.        SCOT ANALYSIS

 

7.1.6.        STRATEGIC ANALYSIS

 

7.2.        Cargill, Inc 

 

7.2.1.        OVERVIEW

 

7.2.2.        PRODUCT PORTFOLIO

 

7.2.3.        KEY INNOVATION SECTOR

 

7.2.4.        STRATEGIC INITIATIVES

 

7.2.5.        SCOT ANALYSIS

 

7.2.6.        STRATEGIC ANALYSIS

 

7.3.           CHR. HANSEN A/S.

 

7.3.1.        OVERVIEW

 

7.3.2.        PRODUCT PORTFOLIO

 

7.3.3.        KEY INNOVATION SECTOR

 

7.3.4.        STRATEGIC INITIATIVES

 

7.3.5.        SCOT ANALYSIS

 

7.3.6.        STRATEGIC ANALYSIS

 

7.4.         DSM N.V.

 

7.4.1.        OVERVIEW

 

7.4.2.        PRODUCT PORTFOLIO

 

7.4.3.        KEY INNOVATION SECTOR

 

7.4.4.        STRATEGIC INITIATIVES

 

7.4.5.        SCOT ANALYSIS

 

7.4.6.        STRATEGIC ANALYSIS

 

7.5.              FRUTAROM 

 

7.5.1.        OVERVIEW

 

7.5.2.        PRODUCT PORTFOLIO

 

7.5.3.        KEY INNOVATION SECTOR

 

7.5.4.        STRATEGIC INITIATIVES

 

7.5.5.        SCOT ANALYSIS

 

7.5.6.        STRATEGIC ANALYSIS

 

7.6.           GARUDA INTERNATIONAL INC. 

 

7.6.1.        OVERVIEW

 

7.6.2.        PRODUCT PORTFOLIO

 

7.6.3.        KEY INNOVATION SECTOR

 

7.6.4.        STRATEGIC INITIATIVES

 

7.6.5.        SCOT ANALYSIS

 

7.6.6.        STRATEGIC ANALYSIS

 

7.7.            KEMIN INDUSTRIES

 

7.7.1.        OVERVIEW

 

7.7.2.        PRODUCT PORTFOLIO

 

7.7.3.        KEY INNOVATION SECTOR

 

7.7.4.        STRATEGIC INITIATIVES

 

7.7.5.        SCOT ANALYSIS

 

7.7.6.        STRATEGIC ANALYSIS

 

7.8.             KONINKLIJKE DSM N.V. 

 

7.8.1.        OVERVIEW

 

7.8.2.        PRODUCT PORTFOLIO

 

7.8.3.        KEY INNOVATION SECTOR

 

7.8.4.        STRATEGIC INITIATIVES

 

7.8.5.        SCOT ANALYSIS

 

7.8.6.        STRATEGIC ANALYSIS

 

7.9.             MAXAROME

 

7.9.1.        OVERVIEW

 

7.9.2.        PRODUCT PORTFOLIO

 

7.9.3.        KEY INNOVATION SECTOR

 

7.9.4.        STRATEGIC INITIATIVES

 

7.9.5.        SCOT ANALYSIS

 

7.9.6.        STRATEGIC ANALYSIS

 

7.10.         MILLIPORESIGMA 

 

7.10.1.    OVERVIEW

 

7.10.2.    PRODUCT PORTFOLIO

 

7.10.3.    KEY INNOVATION SECTOR

 

7.10.4.    STRATEGIC INITIATIVES

 

7.10.5.    SCOT ANALYSIS

 

7.10.6.    STRATEGIC ANALYSIS

 

7.11.         OHLY 

 

7.11.1.    OVERVIEW

 

7.11.2.    PRODUCT PORTFOLIO

 

7.11.3.    KEY INNOVATION SECTOR

 

7.11.4.    STRATEGIC INITIATIVES

 

7.11.5.    SCOT ANALYSIS

 

7.11.6.    STRATEGIC ANALYSIS

 

7.12.        PHARMACON ASA

 

7.12.1.    OVERVIEW

 

7.12.2.    PRODUCT PORTFOLIO

 

7.12.3.    KEY INNOVATION SECTOR

 

7.12.4.    STRATEGIC INITIATIVES

 

7.12.5.    SCOT ANALYSIS

 

7.12.6.    STRATEGIC ANALYSIS

 

7.13.       SPECIALTY BIOTECH CO., LTD

 

7.13.1.    OVERVIEW

 

7.13.2.    PRODUCT PORTFOLIO

 

7.13.3.    KEY INNOVATION SECTOR

 

7.13.4.    STRATEGIC INITIATIVES

 

7.13.5.    SCOT ANALYSIS

 

7.13.6.    STRATEGIC ANALYSIS

 

7.14.       SUPER BETA GLUCAN 

 

7.14.1.    OVERVIEW

 

7.14.2.    PRODUCT PORTFOLIO

 

7.14.3.    KEY INNOVATION SECTOR

 

7.14.4.    STRATEGIC INITIATIVES

 

7.14.5.    SCOT ANALYSIS

 

7.14.6.    STRATEGIC ANALYSIS

 

7.15.        TATE & LYLE PLC 

 

7.15.1.    OVERVIEW

 

7.15.2.    PRODUCT PORTFOLIO

 

7.15.3.    KEY INNOVATION SECTOR

 

7.15.4.    STRATEGIC INITIATIVES

 

7.15.5.    SCOT ANALYSIS

 

7.15.6.    STRATEGIC ANALYSIS

 

 

 

LIST OF TABLES

 

 

 

1.            GLOBAL BETA GULCAN MARKET BY SOURCE 2014-2023 ($ MILLION)

 

2.            GLOBAL BACTERIA BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

3.            GLOBAL FUNGUS BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

4.            GLOBAL YEAST BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

5.            GLOBAL CEREAL BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

6.            GLOBAL ALGAE BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

7.            GLOBAL BETA GULCAN MARKET BY END USER INDUSTRY 2014-2023 ($ MILLION)

 

8.            GLOBAL FOOD & BEVERAGES BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

9.            GLOBAL PERSONAL CARE BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

10.        GLOBAL PHARMACEUTICALS BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

11.        GLOBAL ANIMAL FEED BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

12.        GLOBAL BETA GULCAN MARKET BY CATEGORY 2014-2023 ($ MILLION)

 

13.        GLOBAL INSOLUBLE BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

14.        GLOBAL SOLUBLE BETA GULCAN MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)

 

15.        NORTH AMERICA BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

16.        EUROPE BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

17.        ASIA PACIFIC BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

18.        REST OF THE WORLD BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

 

LIST OF FIGURES

 

 

1.       GLOBAL BETA GULCAN MARKET BY BACTERIA 2014-2023 ($ MILLION)

 

2.       GLOBAL BETA GULCAN MARKET BY FUNGUS  2014-2023 ($ MILLION)

 

3.       GLOBAL BETA GULCAN MARKET BY YEAST 2014-2023 ($ MILLION)

 

4.       GLOBAL BETA GULCAN MARKET BY CEREAL 2014-2023 ($ MILLION)

 

5.       GLOBAL BETA GULCAN MARKET BY ALGAE 2014-2023 ($ MILLION)

 

6.       GLOBAL BETA GULCAN MARKET BY FOOD & BEVERAGES 2014-2023 ($ MILLION)

 

7.       GLOBAL BETA GULCAN MARKET BY PERSONAL CARE 2014-2023 ($ MILLION)

 

8.       GLOBAL BETA GULCAN MARKET BY PHARMACEUTICALS 2014-2023 ($ MILLION)

 

9.       GLOBAL BETA GULCAN MARKET BY ANIMAL FEED 2014-2023 ($ MILLION)

 

10.   GLOBAL BETA GULCAN MARKET BY INSOLUBLE  2014-2023 ($ MILLION)

 

11.   GLOBAL BETA GULCAN MARKET BY SOLUBLE  2014-2023 ($ MILLION)

 

12.   UNITED STATES (U.S.) BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

13.   CANADA BETA GULCAN MARKET2014-2023 ($MILLION)

 

14.   UNITED KINGDOM (UK) TITANIUM DIOXIDEMARKET2014-2023 ($ MILLION)

 

15.   FRANCE BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

16.   GERMANY BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

17.   SPAIN BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

18.   ITALY BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

19.   ROE BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

20.   INDIA BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

21.   CHINA BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

22.   JAPAN BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

23.   KOREA BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

24.   AUSTRALIA BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

25.   ROW APAC BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

26.   LATIN AMERICA BETA GULCAN MARKET 2014-2023 ($ MILLION)

 

27.   MENA BETA GULCAN MARKET 2014-2023 ($ MILLION)